Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Phase II Study Of Tosedostat (TST) In Combination With Either Cytarabine Or Decitabine In Newly Diagnosed Older Patients With Acute Myeloid Leukemia (AML) Or High-Risk Myelodysplastic Syndrome (MDS)
Blood (2013)
  • Pamela S. Becker, University of Washington
  • Paul C. Hendrie, University of Washington
  • Bart L Scott, Fred Hutchinson Cancer Research Center
  • Brent L. Wood, Fred Hutchinson Cancer Research Center
  • Carol Dean, Fred Hutchinson Cancer Research Center
  • Ravinder K Sandhu, Fred Hutchinson Cancer Research Center
  • H. Joachim Deeg, University of Washington
  • Roland B. Walter, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Lixia Wang, Eli Lilly and Company
  • Han Myint, Rush University Medical Center
  • Jack Singer, University of Washington
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
  • John M. Pagel, University of Washington
Link
Disciplines
Publication Date
November 15, 2013
Citation Information
Pamela S. Becker, Paul C. Hendrie, Bart L Scott, Brent L. Wood, et al.. "A Phase II Study Of Tosedostat (TST) In Combination With Either Cytarabine Or Decitabine In Newly Diagnosed Older Patients With Acute Myeloid Leukemia (AML) Or High-Risk Myelodysplastic Syndrome (MDS)" Blood Vol. 122 Iss. 21 (2013) p. 3926 - 3926
Available at: http://works.bepress.com/john-pagel/115/